Immunodiagnostic Systems Holdings PLC, commonly referred to as IDS, is a leading player in the immunodiagnostics industry, headquartered in the United Kingdom. Founded in 1977, IDS has established itself as a pioneer in the development and manufacture of innovative diagnostic solutions, primarily focusing on immunoassay technology for clinical laboratories. With a strong presence in Europe, North America, and Asia, IDS offers a diverse range of products, including automated immunoassay analysers and a comprehensive portfolio of assays. Their unique approach combines advanced technology with a commitment to quality, ensuring reliable and accurate results for healthcare professionals. Recognised for its significant contributions to the field, IDS has achieved notable milestones, including the expansion of its product line and strategic partnerships that enhance its market position. As a trusted name in immunodiagnostics, IDS continues to drive advancements in healthcare diagnostics.
We don't have data for Immunodiagnostic Systems Holdings PLC, but we can show you information about their parent organization instead.
View parent company